(Q27077916)
Statements
425.218±0 dalton
1 reference
937174-76-0 (English)
19 October 2016
C₂₁H₂₇N₇O₃
1 reference
937174-76-0 (English)
20 November 2016
CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N
1 reference
937174-76-0 (English)
20 November 2016
CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N
1 reference
937174-76-0 (English)
20 November 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
937174-76-0 (English)
20 November 2016
2 references
937174-76-0 (English)
20 November 2016
2 references
gsk-690693 (English)
20 November 2016
1 reference
4-{2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methyl-3-butyn-2-ol (English)
19 October 2016
2 references
937174-76-0 (English)
20 November 2016
2 references
GSK-690693 (English)
20 November 2016
1 reference
GSK-690693 (English)
20 November 2016
804-554-1
1 reference
27 December 2018
[No public or meaningful name is available] (English)
CAS no.: 937174-76-0 (English)
1 reference
27 December 2018
[No public or meaningful name is available] (English)
CAS no.: 937174-76-0 (English)
1 reference
GSK690693 (English)
20 November 2016
2 references
gsk-690693 (English)
20 November 2016
1 reference
3D0E (English)
19 October 2016